about
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly peopleGuidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchEvidence that the gene encoding insulin degrading enzyme influences human lifespanBiological markers of amyloid beta-related mechanisms in Alzheimer's diseaseAnalysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia riskBlood-cerebrospinal fluid barrier permeability in Alzheimer's diseaseZinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluidDecreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosusIntrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagementValidation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patientsThe apolipoprotein E polymorphism and the cholesterol-raising effect of coffeeUpdate on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disordersA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersThe past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular eventsAlzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studiesClearance systems in the brain-implications for Alzheimer diseaseAcute and chronic traumatic encephalopathies: pathogenesis and biomarkers.Harmonized diagnostic criteria for Alzheimer's disease: recommendationsRarity of the Alzheimer disease-protective APP A673T variant in the United StatesAltered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementiaTAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's diseaseA Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's DiseaseSoluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairmentClinical heterogeneity of probable Alzheimer's diseaseBACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous systemIncreased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxersCerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamThe transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer diseaseAdvancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational SummitPlasma BDNF levels vary in relation to body weight in femalesComparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up studyCSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's diseaseHypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humansAβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's diseaseAlzheimer's diseaseThe influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathologyNeurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisClinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.Alzheimer's disease.Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
P50
Q22253051-FA98350B-43DB-4E13-ACE1-25E53DB8BA85Q24289435-EDC6F403-28A6-4958-81BB-DE4706B8CE51Q24336770-934E10C7-6858-492F-B562-80F38C00204CQ24622136-44473EF6-F250-4790-B309-67D4E616EBFFQ24631195-6C4C5F44-B8CA-468B-9B0D-4D2CF5780046Q24631720-B204CCC8-A1DD-46D6-9535-B02F3D6CFDF9Q24649556-E53E0625-602F-4D4C-A6BD-FCDCC624D92CQ24793525-C08262B8-F83B-45E6-8FBD-8ED38A766928Q24798439-D4653EBC-9A27-4DD5-A647-283D621EEA23Q24804838-9DA959B7-46FA-4E84-A00D-BE818AF8BE13Q24809651-AB97B538-E3B7-49D1-ADB3-ADB659A0D99BQ26741861-648E64C1-A30F-4F18-A1B3-EFA7FDE690DDQ26745508-6BC9E8AA-86DF-47F7-A839-E85E41EBFD5AQ26781635-492AD626-E695-46BC-AB87-1809FC13AA48Q26798325-27936BAB-FD32-44DB-BADE-D4C5EE6C4130Q26801541-C09AD925-D950-485A-9E88-B27265E5FDFAQ26995259-713B15EE-E0CA-4436-8E40-EAA727F12B95Q27009157-64DE9CF9-02FB-4574-9327-7EF215ACE1D9Q27346292-43C825BC-7C96-486F-8C7E-F3B8BBD0C3AEQ28245852-A74BBBC6-513F-40D2-846F-DB630227ECC0Q28257736-87C541C9-B423-475B-B56E-18D3BB71EE7AQ28276977-9ECBB24C-8661-49EE-B4FB-0B6197AF2BBEQ28303469-E297C67D-53F0-48A2-9C9C-723864B3FFA8Q28319941-7AFD4300-8E7D-4A5A-BCC7-9DB470362EE8Q28480522-101428B1-606B-435E-9598-0C1DF20E0BC7Q28535187-96D6D869-E12D-4A1E-8397-8DAB0851D5D8Q28595520-A26495E9-F277-4C94-8CCD-ED897EF1EF94Q28645892-2CC95FBB-A980-41F3-9078-8F33BA90917FQ28709591-923B895C-7523-4826-8F96-3C95E739CEBEQ28727632-72001ABE-3461-466B-9B75-4103E772A044Q28728080-F8154A1B-1202-4EE9-B10D-9978762554ACQ28728773-6DB48103-D8C7-4EAA-A6E9-5326E8114E86Q28741472-0D50DFD2-051A-4319-8074-7144D1C43BAAQ28743838-0059E7F0-5477-4329-83F9-F2694CE0E077Q29616743-96884DF0-E73D-4AA8-998D-5C1ED4A40CACQ29994562-E803F145-2071-4AF8-9274-C16FEF9C6230Q30224292-1C96962C-AAB2-4A4D-9532-51E1A68543E4Q30235198-402F582C-C992-4C3B-A71E-51539A98134AQ30251865-E6E2A958-4CDC-47AB-9F0D-A6CFFA6A6A4FQ30458193-65DD417A-6822-428C-A305-E086C3106ADB
P50
description
Zweeds onderzoeker
@nl
forsker
@nb
hulumtues
@sq
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Kaj Blennow
@ast
Kaj Blennow
@da
Kaj Blennow
@de
Kaj Blennow
@en
Kaj Blennow
@es
Kaj Blennow
@fr
Kaj Blennow
@nb
Kaj Blennow
@nl
Kaj Blennow
@nn
Kaj Blennow
@sl
type
label
Kaj Blennow
@ast
Kaj Blennow
@da
Kaj Blennow
@de
Kaj Blennow
@en
Kaj Blennow
@es
Kaj Blennow
@fr
Kaj Blennow
@nb
Kaj Blennow
@nl
Kaj Blennow
@nn
Kaj Blennow
@sl
altLabel
Kaj A. Blennow
@en
prefLabel
Kaj Blennow
@ast
Kaj Blennow
@da
Kaj Blennow
@de
Kaj Blennow
@en
Kaj Blennow
@es
Kaj Blennow
@fr
Kaj Blennow
@nb
Kaj Blennow
@nl
Kaj Blennow
@nn
Kaj Blennow
@sl
P214
P1153
56415176000
P166
P21
P214
P27
P31
P735
P7859
lccn-nb2012011005